glp 1 agonist anti inflammatory Frontiers 2024 Multiple Sclerosis Highlight -

Short-acting drugs primarily lower postprandial blood glucose levels by slowing gastric emptying, while long-acting GLP-1 RAs are more effective at reducing fasting blood glucose levels, mainly by promoting insulin secretion and inhibiting glucagon release

GLP-1- based treatments for T2DM, such as GLP-1 receptor agonists, dual and triple agonists that activate GLP-1R, GIPR, and glucagon receptors, and dipeptidyl peptidase-4 (DPP-4) inhibitors have been reviewed here

134979-01-4, CH2COOH-PEG2-NH2.HCl References: [1] Gribble FM, Reimann F

doi: 10.1056/NEJMp2400978 Summary Keywords GIP, GLP-1, GLP-1RA, tirzepatide, diabetes, obesity, cardiovascular disease Citation Liu QK (2024) Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists

Building a long-term partnership with your prescriber Your first appointment is not the finish line

If these methods prove to be unsuccessful with either weight loss or headache relief, pharmaceutical therapies can be considered to augment weight loss and should be combined with core weight management practices